Albert A. Luderer's most recent trade in Bionano Genomics Inc was a trade of 4,000 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Sept. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director, Interim Chief Executive | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 04 Sep 2026 | 4,000 | 8,000 (0%) | 0% | 1.2 | 4,845 | Common Stock |
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director, Interim Chief Executive | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 21 Aug 2026 | 4,000 | 4,000 (0%) | 0% | 1.2 | 4,860 | Common Stock |
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director | 11 Jun 2025 | 2,775 | 2,775 | - | - | Stock Option (Right to Buy) | ||
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director | 18 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | ||
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director | 14 Jun 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | ||
| Bionano Genomics Inc | Dr. Albert A. Luderer, PhD | Director | 09 Jun 2022 | 164,422 | 164,422 | - | - | Stock Option (right to buy) |